BOSTON–(BUSINESS WIRE)– #CRO–Ora announces appointment of Cindy Markham as Chief Commercial Officer
Author: Business Wire
Lumata Health Announces New Clinical Advisory Board to Advance Efforts in Preventing Blindness through Industry-Leading Intelligent Eye Care Management Platform
RALEIGH, N.C. & OKLAHOMA CITY–(BUSINESS WIRE)–Lumata Health, a technology-driven healthcare innovator empowering ophthalmology practices to enhance continuous care for those at risk of blindness from chronic eye diseases, today formally announced its…
Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announces the company’s key priorities and…
Ophthalmic Lasers Market Global Outlook & Forecast 2024-2029, with Key Vendor Profiles for Alcon, Bausch + Lomb, Johnson & Johnson, NIDEK and ZEISS – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Lasers Market – Global Outlook & Forecast 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The Ophthalmic Lasers Market was valued at USD 1.30 billion in 2023, and is projected to reach…
Canyon Labs Announces Strategic Acquisition of iuvo BioScience’s Lab Services and Consulting Businesses to Expand End-to-End Development Solutions
SALT LAKE CITY & ROCHESTER, N.Y.–(BUSINESS WIRE)–Canyon Labs, a global leader in analytical & packaging lab testing and consulting for medical devices and pharmaceuticals, and iuvo BioScience, a full service provider of ophthalmic medical device …
Lumentum Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index
SAN JOSE, Calif.–(BUSINESS WIRE)–Lumentum Holdings Inc. (“Lumentum”), a market-leading designer and manufacturer of innovative optical and photonic products for cloud, networking and industrial applications, announced today that it has received a per…
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Amir H. Shojaei, PharmD, PhD, has joined Harrow as Chief Scientific Officer (CSO). With a remarkable caree…
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national nonprofit organization dedicate…
Cencora Completes Acquisition of Retina Consultants of America
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading management services organization (MSO) of retina specialists. Cenco…
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Chief Financial Officer Sam …
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the su…
Drug Farm Signs Agreement with National Institutes of Health (NIH) to Develop Precision Targeted Treatment for ROSAH Syndrome
GUILFORD, Conn. & ROCKVILLE, Md.–(BUSINESS WIRE)–Drug Farm, a clinical-stage biopharmaceutical company developing innovative treatments targeting innate immunity, announced today the signing of a Cooperative Research and Development Agreement (CRADA)…
Jacques Gilbert Appointed Chief Strategy and Business Development Officer at Topcon Healthcare, Inc.
OAKLAND, N.J.–(BUSINESS WIRE)– #TopconHealthcare–Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is pleased to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Of…
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that its Reconvened Special Meeting of Stockholders held on December 18, 2024 has been adjourned until January 16, 2025 at 1…
GenSight Biologics fait un point sur les discussions réglementaires et sa situation financière
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” ou la “Société”) (Euronext : SIGHT, ISIN: FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniqu…
GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
Aurion Biotech Announces Positive Topline Data for Phase 1/2 Clinical Trial of AURN001, an Allogeneic Cell Therapy Product Candidate for the Treatment of Corneal Edema Secondary to Corneal Endothelial Dysfunction
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced topline data from its Phase 1/2 clinical t…
Local Organ, Eye and Tissue Donors, Living Donors and Recipients to be Honored on the 2025 OneLegacy Donate Life Rose Parade® Float on New Year’s Day
AZUSA, Calif.–(BUSINESS WIRE)–OneLegacy will honor 19 Southern Californians whose lives have been touched by the power of organ, eye and tissue donation on the 2025 OneLegacy Donate Life Rose Parade® float, themed “Let Your Life Soar.” The announceme…
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Viridian Therapeutics Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced positive topline data from t…